Rainer K. Reinscheid

Dr. Rainer K. Reinscheid

Institute of Pharmacology and Toxicology, University Hospital Jena, Friedrich-Schiller-Universität, Jena, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RRRainer K. Reinscheid
Rainer K. Reinscheid
Chiara RuzzaChiara Ruzza
Chiara Ruzza
The Neuropeptide S (NPS) system is a rather ‘young’ transmitter system that was discovered and functionally described less than 20 years ago. This review highlights the progress that has been made in elucidating its pharmacology, anatomical distribution, and functional involvement in a variety of physiological effects, including behavior and immune functions. Early on, genetic variations of the human NPS receptor (NPSR1) have attracted attention and we summarize current hypotheses of genetic linkage with disease and human behaviors. Finally, we review the therapeutic potential of future drugs modulating NPS signaling. This review serves as an introduction to the broad collection of original research papers and reviews from experts in the field that are presented in this Special Issue.

1 April 2021 in Peptides
Verified
Journal Article
Closed access
RRRainer K. Reinscheid
Rainer K. Reinscheid
FMFabrizio Mafessoni
Fabrizio Mafessoni
ALAnnika Lüttjohann
Annika Lüttjohann
KJKay Jüngling
Kay Jüngling
HPHans-Christian Pape
Hans-Christian Pape
SSStefan Schulz
Stefan Schulz

13 June 2022 in Neuroscience
Verified
Journal Article
Open access
CGCelia Garau
Celia Garau
XLXiaobin Liu
Xiaobin Liu
GCGirolamo' Calo
Girolamo' Calo
SSStefan Schulz
Stefan Schulz
RRRainer K. Reinscheid
Rainer K. Reinscheid
Evaluation of stimulus salience is critical for any higher organism, as it allows for prioritizing of vital information, preparation of responses, and formation of valuable memory. The paraventricular nucleus of the thalamus (PVT) has recently been identified as an integrator of stimulus salience but the neurochemical basis and afferent input regarding salience signaling have remained elusive. Here we report that neuropeptide S (NPS) signaling in the PVT is necessary for stimulus salience encoding, including aversive, neutral and reinforcing sensory input. Taking advantage of a striking deficit of both NPS receptor (NPSR1) and NPS precursor knockout mice in fear extinction or novel object memory formation, we demonstrate that intra-PVT injections of NPS can rescue the phenotype in NPS precursor knockout mice by increasing the salience of otherwise low-intensity stimuli, while intra-PVT injections of NPSR1 antagonist in wild type mice partially replicates the knockout phenotype. The PVT appears to provide stimulus salience encoding in a dose- and NPS-dependent manner. PVT NPSR1 neurons recruit the nucleus accumbens shell and structures in the prefrontal cortex and amygdala, which were previously linked to the brain salience network. Overall, these results demonstrate that stimulus salience encoding is critically associated with NPS activity in the PVT.

20 May 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
WSWei Si
Wei Si
XLXiaobin Liu
Xiaobin Liu
HPHans-Christian Pape
Hans-Christian Pape
RRRainer K. Reinscheid
Rainer K. Reinscheid
Conflicting reports about the role of neuropeptide S (NPS) in animal models of psychotic-like behavior and inconsistent results from human genetic studies seeking potential associations with schizophrenia prompted us to reevaluate the effects of NPS in the prepulse inhibition (PPI) paradigm in mice. Careful examination of NPS receptor (NPSR1) knockout mice at different ages revealed that PPI deficits are only expressed in young male knockout animals (<12 weeks of age), that can be replicated in NPS precursor knockout mice and appear strain-independent, but are absent in female mice. PPI deficits can be aggravated by MK-801 and alleviated by clozapine. Importantly, treatment of wildtype mice with a centrally-active NPSR1 antagonist was able to mimic PPI deficits. PPI impairment in young male NPSR1 and NPS knockout mice may be caused by attentional deficits that are enhanced by increasing interstimulus intervals. Our data reveal a substantial NPS-dependent developmental influence on PPI performance and confirm a significant role of attentional processes for sensory-motor gating. Through its influence on attention and arousal, NPS appears to positively modulate PPI in young animals, whereas compensatory mechanisms may alleviate NPS-dependent deficits in older mice.

1 January 2018
Verified
Book Chapter
Closed access
PDF file
RRRainer K. Reinscheid
Rainer K. Reinscheid
OCOlivier Civelli
Olivier Civelli